Verisk Analytics, Inc.
177.99USD
+2.5000 (+1.42%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.93▼ | $1.95 | 2 | 12 |
| Next quarter | $1.98▼ | $1.98 | 5 | 8 |
| Current year | $7.71▲ | $7.65 | 14 | 3 |
| Next year | $8.7▲ | $8.66 | 11 | 6 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.93 | $1.98 | +0.05 (+2.4%) |
| 2026-03-31 | $1.74 | $1.82 | +0.08 (+4.7%) |
| 2025-12-31 | $1.61 | $1.82 | +0.21 (+12.9%) |
| 2025-09-30 | $1.7 | $1.72 | +0.02 (+1.0%) |
273 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $275 $225 | Sep 8, 2026 |
| UBS | Maintained | Neutral | $220 $235 | Jul 30, 2026 |
| Evercore ISI Group | Maintained | In-Line | $222 $223 | Jul 30, 2026 |
| Wells Fargo | Maintained | Overweight | $240 $260 | Jul 30, 2026 |
| Jefferies | Upgraded from Hold | Buy | $192 $235 | Jul 23, 2026 |
| B of A Securities | Maintained | Neutral | $225 $190 | May 19, 2026 |
| JP Morgan | Maintained | Overweight | $220 $230 | Apr 30, 2026 |
| RBC Capital | Reiterated | Outperform | $230 | Mar 30, 2026 |
| Raymond James | Upgraded from Outperform | Strong Buy | $215 $260 | Mar 2, 2026 |
| Wells Fargo | Maintained | Overweight | $223 $240 | Mar 2, 2026 |
| Goldman Sachs | Maintained | Neutral | $239 $206 | Feb 19, 2026 |
| RBC Capital | Maintained | Outperform | $250 $230 | Feb 19, 2026 |
| JP Morgan | Maintained | Overweight | $260 $220 | Feb 19, 2026 |
| Evercore ISI Group | Maintained | In-Line | $250 $216 | Feb 19, 2026 |
| Wells Fargo | Maintained | Overweight | $237 $223 | Feb 19, 2026 |
| Wells Fargo | Maintained | Overweight | $280 $237 | Feb 11, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $290 $270 | Dec 17, 2025 |
| JP Morgan | Maintained | Overweight | $315 $250 | Oct 30, 2025 |
| Evercore ISI Group | Maintained | In-Line | $262 $250 | Oct 30, 2025 |
| RBC Capital | Maintained | Outperform | $314 $250 | Oct 30, 2025 |
| Goldman Sachs | Maintained | Neutral | $315 $239 | Oct 30, 2025 |
| Wells Fargo | Maintained | Overweight | $334 $300 | Oct 30, 2025 |
| Barclays | Upgraded from Equal-Weight | Overweight | $310 $275 | Oct 30, 2025 |
| Rothschild & Co | Downgraded from Neutral | Sell | $280 $220 | Oct 16, 2025 |
| Evercore ISI Group | Maintained | In-Line | $292 $262 | Oct 14, 2025 |
136 filings from 18 insiders · 25 buy / 14 sell over 6m
Officers and directors of VRSK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Shavel LeeDirector; Officer, Chief Executive Officer | ExerciseStock Option | 3.5k | — | — | Sep 1, 2026 |
| Shavel LeeDirector; Officer, Chief Executive Officer | Sell | 3.5k | $193.43 | $684k | Sep 1, 2026 |
| Shavel LeeDirector; Officer, Chief Executive Officer | Exercise | 3.5k | $104.00 | $368k | Sep 1, 2026 |
| MANN ELIZABETHChief Financial Officer | Sell | 400 | $179.95 | $72k | Aug 17, 2026 |
| SHAVEL LEE MChief Executive Officer | Sell | 3.5k | $196.94 | $696k | Aug 3, 2026 |
| SHAVEL LEE MChief Executive Officer | Exercise | 3.5k | $104.00 | $368k | Aug 3, 2026 |
| BECKLES KATHY CARDOfficer | Sell | 2.0k | $195.49 | $395k | Jul 31, 2026 |
| SHAVEL LEE MChief Executive Officer | Sell | 2.5k | $220.00 | $550k | Jul 29, 2026 |
| MANN ELIZABETHChief Financial Officer | Sell | 400 | $192.11 | $77k | Jul 15, 2026 |
| PATIATH PRADIPDirector | Grant | 69 | — | — | Jun 30, 2026 |
| HENDRICK GREGORY S.Director | Grant | 146 | — | — | Jun 30, 2026 |
| PURTILL SABRA RDirector | Grant | 163 | — | — | Jun 30, 2026 |
| LISS SAMUEL G.Director | Grant | 167 | — | — | Jun 30, 2026 |
| PERRY CHRISTOPHER JOHNDirector | Grant | 146 | — | — | Jun 30, 2026 |
| MANN ELIZABETHChief Financial Officer | Sell | 400 | $179.54 | $72k | Jun 15, 2026 |
| LISS SAMUEL G.Director | Sell | 4.7k | $182.21 | $851k | Jun 5, 2026 |
| LISS SAMUEL G.Director | Exercise | 4.7k | $80.93 | $378k | Jun 5, 2026 |
| LISS SAMUEL G.Director | Sell | 6.8k | $177.63 | $1.20M | Jun 2, 2026 |
| LISS SAMUEL G.Director | Exercise | 6.8k | $80.93 | $547k | Jun 2, 2026 |
| HANSEN BRUCE EDWARDDirector | Sell | 2.3k | $174.99 | $409k | Jun 1, 2026 |
No analyst notes on VRSK yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 7 | 8 | 0 | 0 | Buy2.21 |
| 1 mo ago | 4 | 7 | 8 | 0 | 0 | Buy2.21 |
| 2 mo ago | 3 | 7 | 9 | 0 | 0 | Buy2.32 |
| 3 mo ago | 4 | 6 | 9 | 0 | 0 | Buy2.26 |